03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Long Covid
Dr Lawrence Hayes: no photograph is held, so the academic plate is shown instead.
Academic
Dr Lawrence Hayes
Researcher at Lancaster University
Feb 2026MarAprMayJuneJulyAugSeptOctNovto date
1
Quoted in the press, across 1 topic since 3 Feb 2026
02 Quoted on · 1 of 29 topics
Dr Lawrence Hayes: key facts
- Kind of voice
- Academic
- Role
- Researcher at Lancaster University
- Quoted on
- Long Covid
- Press coverage
- Quoted in the press
- Most recently quoted
- 3 Feb 2026
04 The signal · where Dr Lawrence Hayes sits on long covid
Quoted
Quoted in the press on long covid.
Placed by press coverage on this topic only, not across all topics.
- Professor Dmitry PshezhetskiyAcademicProfessorial Research Fellow, Norwich Medical School, University of East AngliaLeading
Dr Charles ShepherdClinicianTrustee and Honorary Medical Adviser, The ME AssociationLeading
Dr. Ewan HunterBusiness leaderChief Data Officer, Oxford BioDynamics PlcLeading- Dr. David PriceAcademicCardiff University
- Yulin GeAcademicProfessor, Department of Radiology, NYU Grossman School of Medicine; senior study author
- Dr Lawrence HayesAcademicResearcher at Lancaster University
- Professor Sonya Marshall-GradisnikAcademicProfessor at Griffith's National Centre for Neuroimmunology and Emerging Diseases
- Dr Kathryn McKinnonClinicianSenior Medical Director (Education), Health Partners Group; Chair, BMA Occupational Medicine Committee
Showing the leading voices and those placed around Dr Lawrence Hayes · See every voice on the topic →
05 On the record · press
What Dr Lawrence Hayes has said
By outlet · bar length shows relative volume
- lancaster.ac.uk
- lep.co.uk
Where Dr Lawrence Hayes has been quoted
- 'Long Covid app' could help sufferers after Lancashire researchlep.co.uk · 3 Feb 2026
- Tracker to help manage Long COVID energy levels created by researcherslancaster.ac.uk
Verbatim
“This trial marks a significant step in understanding how digital tools can support people living with Long COVID. While the intervention didn't outperform standard care, it was safe, well-received, and offers a promising framework for future research in chronic conditions where recovery is less likely.”
“This trial marks a significant step in understanding how digital tools can support people living with Long COVID. While the intervention didn't outperform standard care, it was safe, well-received, and offers a promising framework for future research in chronic conditions where recovery is less likely.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.